Finerenone and Kidney Outcomes in Patients With Heart Failure

🏆 Top 20📊 OpenAlex

Most Cited Paper

in Heart Failure Treatment and Management

18 Months Post-Publication

Class of 2026

“Finerenone and Kidney Outcomes in Patients With Heart Failure”

AuthorsFinnian R Mc Causland et al.

Finnian R. Mc Causland

JournalJournal of the American College of Cardiology

Brigham and Women's Hospital

Citations62

DOI10.1016/j.jacc.2024.10.091

A research intelligence initiative by Pepkio

pri.pepkio.com/top-papers/heart-failure-treatment-and-management/2026/

Topics

Finerenone · Heart failure · Heart failure with mildly reduced ejection fraction · Heart failure with preserved ejection fraction · Chronic Kidney Disease · Type 2 diabetes · Renal outcomes · Renal dysfunction · Renal dysfunction · Urine albumin-creatinine ratio · Albuminuria · microalbuminuria · Macroalbuminuria · Kidney failure · Dialysis · Renal transplantation · Mineralocorticoid receptor antagonists · Nonsteroidal mineralocorticoid receptor antagonist · Randomized controlled trial · Placebo-controlled trial · FINEARTS-HF trial · Kidney-protective effects · Renal composite endpoint · Left ventricular ejection fraction · Prespecified analysis · Renal dysfunction · cardiorenal syndrome · Hazard ratio · Disease progression biomarker · Renal dysfunction

Share on X

Cite this ranking

Pepkio Research Index (PRI). Topics and Trends in Most Cited Heart Failure Treatment and Management Papers, Class of 2026. https://pri.pepkio.com/top-papers/heart-failure-treatment-and-management/2026. Accessed 2026-07-13.

Zheng Su, Tinsley Li, Thematic Shifts in Early-High-Impact Cancer Genomics and Diagnostics Research: A Bibliometric and Semantic Analysis. bioRxiv 2026.07.04.736459; doi: https://doi.org/10.64898/2026.07.04.736459